Shree Pacetronix's joint MD just put ₹2.56 cr of his own money into the stock
Akash Sethi's stake jumped from 8.76% to 13.51% after acquiring 1,78,000 shares in an off-market deal worth ~4.7% of the ₹54 crore company.
— 2 earlier stories on Shree Pacetronix Ltd. →What's new
- Joint MD Akash Sethi acquired 1,78,000 shares via off-market transfer from Bio Pace Technology INC.
- His voting stake increased from 8.76% to 13.51% of the cardiac-device maker's equity.
- He already holds warrants convertible into another 1.50 lakh shares.
Why this matters
For a company worth ₹54 crore, deploying ₹2.56 crore of personal capital is a significant commitment from a senior insider. It directly increases the joint MD's alignment with minority shareholders and removes a block from the share register.
What we're watching
- Whether Sethi converts his outstanding warrants for another 1.50 lakh shares.
- Any further stakebuilding by Sethi or other insiders.
- Bio Pace Technology's remaining position after this off-market transfer.
The full read
Akash Sethi is the joint managing director of Shree Pacetronix, a ₹54 crore cardiac-device maker. He just bought 1,78,000 shares from Bio Pace Technology in an off-market deal valued at about ₹2.56 crore. That's nearly 4.7% of the company's entire market value deployed in one transaction. His direct stake jumped from 8.76% to 13.51%. A big move. He already holds warrants convertible into 1.50 lakh more shares, so his potential exposure is even higher. The seller, Bio Pace Technology, has cleanly exited a position. For a promoter already running the company, this is a clear, voluntary allocation of personal capital into the stock. The open question is whether this is a one-off or the beginning of a larger accumulation.
Questions answered
- Who sold the shares and at what price?
- Bio Pace Technology INC sold 1,78,000 shares to the promoter in an off-market deal. The filing does not disclose the price, but the analyst rationale estimates the value at approximately ₹2.56 crore.
- How does this affect the company's shareholding structure?
- The transaction materially alters the cap table: Sethi's direct voting stake jumped 475 basis points to 13.51%. For a nano-cap firm, such a shift in insider ownership is a notable structural change.
- What is the full extent of Sethi's potential exposure?
- His direct holding is now 13.51%. He also holds warrants convertible into 1.50 lakh additional shares, which would further increase his stake upon exercise.
- Why is a **₹2.56 crore** deal for a **₹54 crore** company significant?
- The acquisition represents roughly 4.7% of the entire market capitalization. For a promoter to deploy that scale of personal capital in a single block trade is a strong confidence signal from an insider who knows the business intimately.
Story so far
All notes on SHREEPAC →- 10 Jun 2026 · 5:22 PM IST Shree Pacetronix's joint MD just put ₹2.56 cr of his own money into the stock
- 16d ago Shree Pacetronix's profit surges 300% on leaner balance sheet
- 16d ago Shree Pacetronix checks its annual boxes